Baki Topal: Clinical Trials

2 completed, 1 terminated, 1 withdrawn. 2 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 1, Terminated 1
Phase 3	1	Completed 1

Follow Baki Topal: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer Durvalumab 50 MG/ML, Tremelimumab, Gemcitabine - Pancreatic Cancer Non-resectable	Phase 2	Completed	Baki Topal	12	2020-05-09	2024-09-19
Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery Surgery, Pancreatic Tumour		Withdrawn	Baki Topal		2012-11-01	2013-09-17
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer Cytoreductive Surgery (CRS) plus Hyperthermic Intraoperative Peritoneal Chemotherapy with Cisplatin (HIPC) - Peritoneal Carcinomatosis, Gastrointestinal Cancer	Phase 2	Terminated	Baki Topal	34	2010-07-01	2015-12-02
Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy Pancreaticojejunostomy, Pancreaticogastrostomy - Tumors	Phase 3	Completed	Baki Topal	336	2009-06-01	2012-09-12

Conditions studied

Neoplasms (3)  ·  Pancreatic Neoplasms (2)  ·  Gastrointestinal Neoplasms (1)  ·  Hemorrhage (1)  ·  Peritoneal Neoplasms (1)

Interventions

Cisplatin (1)  ·  Cytoreduction Surgical Procedures (1)  ·  Gemcitabine (1)  ·  Pancreaticojejunostomy (1)  ·  durvalumab (1)  ·  tremelimumab (1)

Countries

Belgium (4)

Top investigators

Claude Bertrand, MD (1)  ·  Franky Vansteenkiste, MD (1)  ·  Geert Roeyen, MD (1)  ·  Henk Thieren, MD (1)  ·  Jean Closset, MD, PhD (1)  ·  Jean-Francois Gigot, MD, PhD (1)  ·  Joseph Weerts, MD (1)  ·  Marc Janssens, MD (1)  ·  Steven Pauli, MD (1)  ·  Tom Feryn, MD (1)

Results publications

PMID 20306901, PMID 23643139, PMID 27520560, PMID 29149865

NIH funding

2018 (1)